Floatz logo

Semaglutide

Spinal Cord Injuries

James J. Peters Veterans Affairs Medical Centerprotein_peptidePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Spinal Cord Injuries cohort.

Asset / SponsorPhaseRating
Pregabalin
Ju Seok Ryu
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
MetroHealth Medical Center
Phase 4BB
VENLOR
University of Washington
Phase 4BB
Brivaracetam
University of Minnesota
Phase 3BB
Amitriptyline
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 4BB

View all 42 →

Same molecule, other indications

Semaglutide is also rated in:

metabolic diseaseDormant
A
Indicative ·
81 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →